Clinical Trial: A Study on the Efficacy and Safety of NALIRIFOX in Combination with Ivonescimab as First-Line Treatment for Locally Advanced or Metastatic Ampullary Cancer (China)

China, Nov. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study on the Efficacy and Safety of NALIRIFOX in Combination with Ivonescimab as First-Line Treatment for Locally Advanced or Metastatic Ampullary Cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600136490

Registration Time: 2026/11/11

Type: Interventional study

Primary Sponsor: West China Hospital of Sichuan University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=351557

Published by HT Digital Content Services with permission from Health Daily Digest....